Gradient Capital Advisors, LLC Immuno Precise Antibodies Ltd. Transaction History
Gradient Capital Advisors, LLC
- $296 Million
- Q3 2024
A detailed history of Gradient Capital Advisors, LLC transactions in Immuno Precise Antibodies Ltd. stock. As of the latest transaction made, Gradient Capital Advisors, LLC holds 26,808 shares of IPA stock, worth $12,599. This represents 0.01% of its overall portfolio holdings.
Number of Shares
26,808
Previous 26,808
-0.0%
Holding current value
$12,599
Previous $27,000
37.04%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding IPA
# of Institutions
22Shares Held
1.65MCall Options Held
14.1KPut Options Held
6.9K-
Ingalls & Snyder LLC New York, NY1.3MShares$608,8570.06% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny60.3KShares$28,3410.0% of portfolio
-
Bank Of Montreal Toronto, A657.8KShares$27,1690.0% of portfolio
-
Northern Trust Corp Chicago, IL50.7KShares$23,8430.0% of portfolio
-
Cibc World Market Inc. Toronto, A641.2KShares$19,3640.0% of portfolio
About ImmunoPrecise Antibodies Ltd.
- Ticker IPA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,836,700
- Market Cap $11.7M
- Description
- ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and provision of related services in the United States, Canada, Europe, Australia, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth ...